Symptomtext
This case involves patients with an unknown age and gender who received an expired dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] with no reported adverse event (expired product administered). The patient's medical history, past medical treatments, concomitant medications, vaccinations, and family history were not provided. On an unknown date, the patients received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number: UT7035NA and expiry date: 30-Jun-2021) via unknown route in unknown administration site for prophylactic vaccination. It was case of an actual medication error due to expired vaccine used (latency: same day). It was reported "The caller stated that there were several employees that received the expired dose of FLUZONE QUADRIVALENT Prefilled syringe (PFS). The caller estimated about NINE employees, but did not have any patient specific information to provide. The caller did not know the date of administration." At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.